Predicting risk of chronic liver disease in Chinese adults: External validation of the CLivD score.
作者信息
Pang Yuanjie, Åberg Fredrik, Chen Zhengming, Li Liming, Kartsonaki Christiana
机构信息
Department of Epidemiology & Biostatistics, School of Public Health, Peking University, Beijing 100191, China; Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, China.
Transplantation and Liver Surgery, HUCH Meilahti Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
出版信息
J Hepatol. 2024 Jun;80(6):e264-e266. doi: 10.1016/j.jhep.2023.12.022. Epub 2024 Jan 4.
Abstract
摘要
相似文献
1
Predicting risk of chronic liver disease in Chinese adults: External validation of the CLivD score.
J Hepatol. 2024 Jun;80(6):e264-e266. doi: 10.1016/j.jhep.2023.12.022. Epub 2024 Jan 4.
2
Comparison of models to predict incident chronic liver disease: a systematic review and external validation in Chinese adults.
BMC Med. 2024 Dec 31;22(1):601. doi: 10.1186/s12916-024-03754-9.
3
Large-Scale Evaluation and Liver Disease Risk Prediction in Finland's National Electronic Health Record System: Feasibility Study Using Real-World Data.
JMIR Med Inform. 2025 Apr 2;13:e62978. doi: 10.2196/62978.
4
Changes over time in the Chronic Liver Disease risk score predict liver-related outcomes: longitudinal analysis of the Whitehall II study.
Scand J Gastroenterol. 2023 Feb;58(2):170-177. doi: 10.1080/00365521.2022.2113130. Epub 2022 Aug 22.
5
Combined use of the CLivD score and FIB-4 for prediction of liver-related outcomes in the population.
Hepatology. 2024 Jul 1;80(1):163-172. doi: 10.1097/HEP.0000000000000707. Epub 2023 Dec 19.
6
A Simple Clinical Risk Score (CHEST) for Predicting Incident Atrial Fibrillation in Asian Subjects: Derivation in 471,446 Chinese Subjects, With Internal Validation and External Application in 451,199 Korean Subjects.
Chest. 2019 Mar;155(3):510-518. doi: 10.1016/j.chest.2018.09.011. Epub 2018 Oct 4.
7
The regional disparities in liver disease comorbidity among elderly Chinese based on a health ecological model: the China Health and Retirement Longitudinal Study.
BMC Public Health. 2024 Apr 23;24(1):1123. doi: 10.1186/s12889-024-18494-x.
8
[Early diagnosis of liver diseases].
Internist (Berl). 2005 Apr;46(4):411-20. doi: 10.1007/s00108-005-1378-9.
9
Combined use of the ELF test and CLivD score improves prediction of liver-related outcomes in the general population.
Liver Int. 2023 Oct;43(10):2107-2115. doi: 10.1111/liv.15681. Epub 2023 Jul 23.
10
Risk stratification of decompensation using liver stiffness and platelet counts in compensated advanced chronic liver disease (CHESS2102).
J Hepatol. 2022 Jan;76(1):248-250. doi: 10.1016/j.jhep.2021.10.006. Epub 2021 Oct 15.
引用本文的文献
1
Large-Scale Evaluation and Liver Disease Risk Prediction in Finland's National Electronic Health Record System: Feasibility Study Using Real-World Data.
JMIR Med Inform. 2025 Apr 2;13:e62978. doi: 10.2196/62978.
2
Evidence-based criteria for identifying at-risk individuals requiring liver disease screening.
Hepatol Commun. 2025 Mar 21;9(4). doi: 10.1097/HC9.0000000000000679. eCollection 2025 Apr 1.
3
Prediction of major liver-related events in the population using prognostic models.
Gastroenterol Rep (Oxf). 2025 Mar 14;13:goaf028. doi: 10.1093/gastro/goaf028. eCollection 2025.
本文引用的文献
1
Life-course adiposity and severe liver disease: a Mendelian randomization analysis.
Obesity (Silver Spring). 2023 Dec;31(12):3077-3085. doi: 10.1002/oby.23913. Epub 2023 Oct 23.
2
A good step toward low-cost prognostication of liver-related outcome awaits more validation.
J Hepatol. 2022 Sep;77(3):887-889. doi: 10.1016/j.jhep.2022.04.008. Epub 2022 Apr 20.
3
Development and validation of a model to predict incident chronic liver disease in the general population: The CLivD score.
J Hepatol. 2022 Aug;77(2):302-311. doi: 10.1016/j.jhep.2022.02.021. Epub 2022 Mar 8.
4
Observational and Genetic Associations of Body Mass Index and Hepatobiliary Diseases in a Relatively Lean Chinese Population.
JAMA Netw Open. 2020 Oct 1;3(10):e2018721. doi: 10.1001/jamanetworkopen.2020.18721.
5
Calibration: the Achilles heel of predictive analytics.
BMC Med. 2019 Dec 16;17(1):230. doi: 10.1186/s12916-019-1466-7.
6
Global liver disease burdens and research trends: Analysis from a Chinese perspective.
J Hepatol. 2019 Jul;71(1):212-221. doi: 10.1016/j.jhep.2019.03.004. Epub 2019 Mar 12.
7
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.
Lancet. 2018 Nov 10;392(10159):1736-1788. doi: 10.1016/S0140-6736(18)32203-7. Epub 2018 Nov 8.
8
Diabetes, Plasma Glucose, and Incidence of Fatty Liver, Cirrhosis, and Liver Cancer: A Prospective Study of 0.5 Million People.
Hepatology. 2018 Oct;68(4):1308-1318. doi: 10.1002/hep.30083.
9
China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up.
Int J Epidemiol. 2011 Dec;40(6):1652-66. doi: 10.1093/ije/dyr120. Epub 2011 Sep 21.
Zotero 插件